Tranexamic acid, a synthetic derivative of the amino acid lysine, exerts its primary mechanism of action by competitively binding to plasminogen, thereby blocking its interaction with fibrin. This inhibition prevents the activation of plasmin, an enzyme responsible for the breakdown of fibrin clots. By inhibiting plasmin-mediated fibrinolysis, tranexamic acid promotes the stabilization of existing clots and reduces excessive bleeding. This mechanism is particularly relevant in situations where enhanced fibrinolysis contributes to abnormal or excessive bleeding, making tranexamic acid a valuable agent in various clinical settings to control and prevent excessive blood loss.
- Used in trauma cases to control bleeding, a critical intervention for accidents and injuries.
- Used post-delivery to manage heavy bleeding, aiding in the recovery process for new mothers.
- Used in dental procedures to control bleeding, making oral surgeries safer and more comfortable.
Composition
Each capsule contains:
- Tranexamic Acid: 500 mg
Suggested Usage
- As directed by a registered medical practitioner.